MEMANTINE HYDROCHLORIDE | A206028 | LUPIN LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Forest Laboratories, LLC et al v. Lupin Limited et al 7 patentsANDA 206028, 205784, 205783, 205365memantine hydrochloride | D. Del. | 2014-08-15 | Terminated 2018-03-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4384
per ea
Lowest NADAC/Unit
$0.3152
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68180024906MEMANTINE HCL ER 28 MG CAPSULE | $0.4384 | EA | Generic | — | 2026-06-17 |
| 68180024909MEMANTINE HCL ER 28 MG CAPSULE | $0.4384 | EA | Generic | — | 2026-06-17 |
| 68180024806MEMANTINE HCL ER 21 MG CAPSULE | $0.3287 | EA | Generic | — | 2026-06-17 |
| 68180024709MEMANTINE HCL ER 14 MG CAPSULE | $0.3213 | EA | Generic | — | 2026-06-17 |
| 68180024706MEMANTINE HCL ER 14 MG CAPSULE | $0.3213 | EA | Generic | — | 2026-06-17 |
| 68180024606MEMANTINE HCL ER 7 MG CAPSULE | $0.3152 | EA | Generic | — | 2026-06-17 |
| 00904673461MEMANTINE HCL ER 7 MG CAPSULE | $0.3152 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.